Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study

Overview of attention for article published in Neuropsychiatric Disease and Treatment, September 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

Effects of MAO-B inhibitors on non-motor symptoms and quality of life in Parkinson’s disease: A systematic review

Article in npj Parkinson's Disease (June 2022)

Rasagiline, sleep quality and well-being in Parkinson’s disease: a pilot study

Article in Neurological Sciences (March 2022)

Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson’s Disease: Past, Present, and Future

Article in Journal of Parkinson's Disease (February 2022)